Zijie Pei

Zijie Pei


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2021 in Stem Cells International
Verified
Journal Article
Open access
PDF file
MLMingshan Li
Mingshan Li
ZPZijie Pei
Zijie Pei
HZHongtao Zhang
Hongtao Zhang
JQjing qu
jing qu
Background. Currently, a heterogeneous category of noncoding RNAs (ncRNA) that directly regulate the expression or function of protein-coding genes is shown to have an effect on the fate decision of stem cells. However, the detailed regulatory roles of ncRNAs in myogenic and cardiomyogenic differentiation of mouse C3H10T1/2 mesenchymal stem cells (MSCs) are far from clear. Methods. In this study, 5-azacytidine- (5-AZA-) treated C3H10T1/2 cells were differentiated into myocyte-like and cardiomyocyte-like cells. Next, ncRNA associated with myogenic and cardiomyogenic differentiation was identified using high-throughput RNA sequencing (RNA-seq) data. Bioinformatics analysis was conducted to identify the differentially expressed ncRNAs and the related signaling pathways. Results. Myotube-like structure was formed after 5-AZA treatment of C3H10T1/2 cells. In addition, myogenic and cardiomyogenic differentiation-related genes like GATA4, cTnt, MyoD, and Desmin were upregulated significantly after the 5-AZA treatment. Totally, 1538 differentially expressed lncRNAs and 3398 differentially expressed mRNAs were identified, including 1175 upregulated and 363 downregulated lncRNAs and 2429 upregulated and 969 downregulated mRNAs. In addition, 46 differentially expressed circRNAs were identified, including 25 upregulated and 21 downregulated circRNAs. Moreover, the differentially expressed mRNAs were enriched into 5 significant pathways, including those for focal adhesion, ECM-receptor interaction, PI3K-AKT signaling pathway, PPAR signaling pathway, and Tyrosine metabolism. Conclusions. A systematic view of the expression of ncRNAs in myogenic and cardiomyogenic differentiation of MSCs was provided in the study.

7 October 2025 in Nutrition & Metabolism
Verified
Journal Article
Open access
PDF file
ZHZhiyuan He
Zhiyuan He
JZJiangping Zeng
Jiangping Zeng
WDWenquan Ding
Wenquan Ding
RXRui Xie
Rui Xie
YQYa Qian
Ya Qian
QWQian Wu
Qian Wu
Lipid accumulation product (LAP) has recently gained attention as a novel indicator of metabolic dysfunction. However, the association between LAP and sarcopenia, a metabolic condition characterized by loss of muscle mass, strength, and function, remains unclear. This study aimed to explore the relationship between LAP and both the prevalence and incidence of sarcopenia using data from the China Health and Retirement Longitudinal Study (CHARLS). Sarcopenia was defined according to the criteria established by the Asian Working Group for Sarcopenia in 2019. LAP was calculated using waist circumference and triglyceride levels. A cross-sectional analysis was performed with 7,004 participants from the baseline survey, utilizing logistic regression models to evaluate the association between LAP and sarcopenia prevalence. Additionally, a longitudinal cohort analysis involved 4,484 individuals who were free of sarcopenia at baseline and followed from 2011 to 2015. Cox proportional hazards models were employed to assess the longitudinal association between baseline LAP levels and incident sarcopenia. Furthermore, restricted cubic spline regression (RCS) and subgroup analyses were conducted to explore potential nonlinear relationships and differences across various subgroups. Receiver operating characteristic (ROC) curves was used to evaluate the discriminatory ability of LAP for identifying sarcopenia. Cross-sectional analyses and RCS revealed a significant inverse linear relationship between LAP and the prevalence of sarcopenia [odds ratio (OR) = 0.95, 95% confidence interval (CI): 0.94–0.96]. Participants within the highest LAP tertile demonstrated substantially lower odds of sarcopenia compared to those in the lowest tertile (OR = 0.21, 95% CI: 0.14–0.31). Longitudinal analyses similarly indicated that elevated LAP levels were associated with reduced sarcopenia incidence, with the highest LAP tertile associated with notably decreased risk (HR = 0.17, 95% CI: 0.11–0.27). The nonlinear pattern identified through RCS analysis indicated significant risk reductions up to a LAP threshold of 27.577. Furthermore, subgroup analyses consistently supported this inverse association across various demographic and clinical subgroups. Finally, diagnostic performance of LAP was assessed using the ROC curve (0.763 ([CI]: 0.744–0.783) in the longitudinal study). Elevated LAP levels are inversely associated with both the prevalence and incidence of sarcopenia among middle-aged and elderly adults in China. These findings suggest LAP could serve as a useful metabolic indicator for predicting reduced sarcopenia risk, warranting additional studies to confirm and further elucidate these relationships.

3 October 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
PZPiqian Zhao
Piqian Zhao
ZCZhe Chen
Zhe Chen
YWYa Wen
Ya Wen
HZHongtao Zhang
Hongtao Zhang
LWLiangyuan Wen
Liangyuan Wen
ZPZijie Pei
Zijie Pei
Background: To better understand the preventive or therapeutic clinical interventions that may be supported by the association between rheumatoid arthritis (RA) and postural deformities including hallux valgus, flat foot, and scoliosis, this study was conducted using Mendelian randomization (MR) analysis. It aimed to investigate whether RA is causally associated with postural deformities in European populations.Methods: Summary-level data on RA and postural deformities were obtained from the IEU OpenGWAS project and Finngen database, respectively. LDSC regression analysis was conducted to assess the genetic correlation between these diseases. The inverse variance weighting (IVW) method was employed as the primary approach for two-sample MR analyses to evaluate causality. Supplementary methods included MR-Egger, maximum likelihood, weighted median, and cML-MA. To test for potential horizontal pleiotropy, we performed the MR-Egger intercept test, cML-MA, and secondary analyses after excluding confounders. Additionally, mediation analyses were conducted using two-step MR.Results: The IVW method revealed RA to be causally associated with hallux valgus (OR 1.132, 95% CI 1.087-1.178, P < 0.001) and flat foot (OR 1.197, 95% CI 1.110-1.291, P < 0.001). Among postural deformities, hallux valgus was causally associated with flat foot (OR 1.823, 95% CI 1.569-2.119, P < 0.001) and scoliosis (OR 1.150, 95% CI 1.027-1.287, P < 0.05). No significant horizontal pleiotropy was detected. Moreover, mediation analyses indicated that hallux valgus mediates the effect of RA on flat foot (mediation effect 0.024, 95% CI 0.005-0.044, P < 0.05), with a mediation proportion of 41.31%.Conclusion: These findings indicate a potential causal association between genetically predicted RA and both hallux valgus and flat foot. Furthermore, hallux valgus serves as a mediator in the pathway from RA to flat foot. This underscores the importance of early screening and preventive treatment of foot deformities in RA patients. Further research is necessary to determine the applicability of these findings in non-European populations.

25 August 2026 in Functional & Integrative Genomics
Verified
Journal Article
Closed access
PDF file
LHLiangkun Huang
Liangkun Huang
YWYa Wen
Ya Wen
HXHanzhe Xu
Hanzhe Xu
ZZZe Zhang
Ze Zhang
ZPZijie Pei
Zijie Pei
FSFengpo Sun
Fengpo Sun

14 April 2026 in Biological Procedures Online
Verified
Journal Article
Open access
LHLiangkun Huang
Liangkun Huang
ZPZhongyu Peng
Zhongyu Peng
YWYa Wen
Ya Wen
ZZZe Zhang
Ze Zhang
ZPZijie Pei
Zijie Pei
LWLiangyuan Wen
Liangyuan Wen
Oxidative stress arises from disrupted equilibrium between reactive oxygen species generation and cellular antioxidant capacity, serving as a pivotal mechanism in inflammatory pathology, particularly osteoarthritis development. The progression of osteoarthritis-related pain may additionally involve oxidative stress through its activation of nociceptive signaling pathways, but the mechanism of its influence on the progression of osteoarthritis is not yet unanimous. The study utilized publicly available sequencing data, which included specimens from patients with osteoarthritis and matched healthy controls, retrieved from GEO database, and combined them after removing batch effects. A multi-step analytical approach was employed to identify pivotal diagnostic biomarkers for osteoarthritis. This strategy encompassed examining differential gene expression, constructing protein-protein interaction networks, applying machine learning algorithms, and assessing co-expression patterns. Subsequently, a diagnostic framework incorporating a nomogram was developed based on these candidate genes. To discern distinct patient subgroups, cluster analysis was conducted. Further investigations into the underlying biology revealed divergent functional pathways and immune cell infiltration landscapes across the identified subtypes, highlighting the putative roles of the key biomarkers. We investigated the effects of FKBP5 on osteoarthritis through both in vivo and in vitro experiments, examining chondrocyte proliferation capacity, apoptosis, cellular senescence, mitochondrial function, and cartilage degeneration. We successfully screened the key genes PPARGC1A, FKBP5, and MMP13 for the diagnosis of osteoarthritis, constructed a diagnostic model and a nomogram of osteoarthritis, and verified their excellent diagnostic ability. Based on these core genes we classified osteoarthritis into two subtypes. Enrichment analysis and immune infiltration analysis confirmed that FKBP5 regulates the immune microenvironment in osteoarthritis and influences the progression of osteoarthritis. Both in vivo and in vitro experiments confirmed that FKBP5 overexpression enhances chondrocyte viability, proliferative capacity, and mitochondrial function under inflammatory conditions, while reducing cellular senescence, apoptosis, and cartilage degeneration. FKBP5 may serve as a potential therapeutic target for osteoarthritis intervention. Our study identified distinct molecular subtypes of osteoarthritis by analyzing genes associated with oxidative stress. Furthermore, we found that FKBP5 exerts a positive regulatory effect on chondrocyte function and mitigates cartilage degeneration in the osteoarthritis environment. This provides new insights for personalized treatment of osteoarthritis. The online version contains supplementary material available at 10.1186/s12575-026-00336-2.